ResMed Revenue 2010-2024 | RMD
- ResMed revenue for the quarter ending March 31, 2024 was $1.197B, a 7.17% increase year-over-year.
- ResMed revenue for the twelve months ending March 31, 2024 was $4.584B, a 14.16% increase year-over-year.
- ResMed annual revenue for 2023 was $4.223B, a 18.02% increase from 2022.
- ResMed annual revenue for 2022 was $3.578B, a 11.93% increase from 2021.
- ResMed annual revenue for 2021 was $3.197B, a 8.11% increase from 2020.
ResMed Annual Revenue (Millions of US $) |
|
---|---|
2023 | $4,223 |
2022 | $3,578 |
2021 | $3,197 |
2020 | $2,957 |
2019 | $2,607 |
2018 | $2,340 |
2017 | $2,067 |
2016 | $1,839 |
2015 | $1,679 |
2014 | $1,555 |
2013 | $1,514 |
2012 | $1,369 |
2011 | $1,243 |
2010 | $1,092 |
2009 | $921 |
ResMed Quarterly Revenue (Millions of US $) |
|
---|---|
2024-03-31 | $1,197 |
2023-12-31 | $1,163 |
2023-09-30 | $1,102 |
2023-06-30 | $1,122 |
2023-03-31 | $1,117 |
2022-12-31 | $1,034 |
2022-09-30 | $950 |
2022-06-30 | $915 |
2022-03-31 | $865 |
2021-12-31 | $895 |
2021-09-30 | $904 |
2021-06-30 | $876 |
2021-03-31 | $769 |
2020-12-31 | $800 |
2020-09-30 | $752 |
2020-06-30 | $770 |
2020-03-31 | $769 |
2019-12-31 | $736 |
2019-09-30 | $681 |
2019-06-30 | $705 |
2019-03-31 | $662 |
2018-12-31 | $651 |
2018-09-30 | $588 |
2018-06-30 | $624 |
2018-03-31 | $592 |
2017-12-31 | $601 |
2017-09-30 | $524 |
2017-06-30 | $557 |
2017-03-31 | $514 |
2016-12-31 | $530 |
2016-09-30 | $465 |
2016-06-30 | $519 |
2016-03-31 | $454 |
2015-12-31 | $455 |
2015-09-30 | $412 |
2015-06-30 | $453 |
2015-03-31 | $422 |
2014-12-31 | $423 |
2014-09-30 | $380 |
2014-06-30 | $415 |
2014-03-31 | $398 |
2013-12-31 | $384 |
2013-09-30 | $358 |
2013-06-30 | $415 |
2013-03-31 | $384 |
2012-12-31 | $377 |
2012-09-30 | $340 |
2012-06-30 | $372 |
2012-03-31 | $349 |
2011-12-31 | $333 |
2011-09-30 | $315 |
2011-06-30 | $342 |
2011-03-31 | $313 |
2010-12-31 | $306 |
2010-09-30 | $282 |
2010-06-30 | $292 |
2010-03-31 | $279 |
2009-12-31 | $275 |
2009-09-30 | $247 |
2009-06-30 | $252 |
2009-03-31 | $228 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $27.817B | $4.223B |
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $179.530B | 23.51 |
Stryker (SYK) | United States | $127.352B | 30.50 |
Boston Scientific (BSX) | United States | $112.306B | 35.77 |
Medtronic (MDT) | Ireland | $99.209B | 14.85 |
EssilorLuxottica (ESLOY) | France | $98.424B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $40.079B | 0.00 |
Haleon (HLN) | United Kingdom | $38.036B | 27.77 |
Terumo (TRUMY) | Japan | $24.149B | 34.10 |
Koninklijke Philips (PHG) | Netherlands | $22.914B | 18.19 |
Zimmer Biomet Holdings (ZBH) | United States | $21.863B | 13.97 |
Baxter (BAX) | United States | $16.740B | 11.90 |
Insulet (PODD) | United States | $13.811B | 61.24 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.789B | 0.00 |
Demant (WILYY) | Denmark | $9.175B | 0.00 |
BellRing Brands (BRBR) | United States | $7.686B | 36.15 |
Bio-Rad Laboratories (BIO) | United States | $7.632B | 24.96 |
Lantheus Holdings (LNTH) | United States | $5.441B | 13.56 |
Haemonetics (HAE) | United States | $4.232B | 20.87 |
GN Store Nord (GNNDY) | Denmark | $4.129B | 23.18 |
Perrigo (PRGO) | Ireland | $3.543B | 10.74 |
Prestige Consumer Healthcare (PBH) | United States | $3.408B | 16.22 |
Neogen (NEOG) | United States | $3.277B | 31.52 |
ICU Medical (ICUI) | United States | $2.864B | 25.27 |
TG Therapeutics (TGTX) | United States | $2.830B | 79.61 |
Envista Holdings (NVST) | United States | $2.808B | 11.59 |
Agios Pharmaceuticals (AGIO) | United States | $2.387B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.363B | 46.25 |
QuidelOrtho (QDEL) | United States | $2.100B | 11.66 |
LeMaitre Vascular (LMAT) | United States | $1.822B | 53.41 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.723B | 0.00 |
Warby Parker (WRBY) | United States | $1.589B | 0.00 |
InMode (INMD) | Israel | $1.462B | 7.77 |
AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
Verano Holdings (VRNOF) | United States | $1.228B | 0.00 |
AtriCure (ATRC) | United States | $1.065B | 0.00 |
Owens & Minor (OMI) | United States | $1.013B | 8.83 |
National Vision Holdings (EYE) | United States | $0.980B | 31.20 |
BioLife Solutions (BLFS) | United States | $0.932B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.676B | 14.40 |
PetIQ (PETQ) | United States | $0.672B | 21.72 |
Evolus (EOLS) | United States | $0.667B | 0.00 |
Surmodics (SRDX) | United States | $0.598B | 37.47 |
VAREX IMAGING (VREX) | United States | $0.596B | 14.02 |
Valneva SE (VALN) | France | $0.505B | 0.00 |
ZimVie (ZIMV) | United States | $0.495B | 42.19 |
Quanterix (QTRX) | United States | $0.487B | 0.00 |
Canopy Growth (CGC) | Canada | $0.477B | 0.00 |
Biote (BTMD) | United States | $0.475B | 10.93 |
Jin Medical (ZJYL) | China | $0.398B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.376B | 0.00 |
Cerus (CERS) | United States | $0.314B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.302B | 9.71 |
Zynex (ZYXI) | United States | $0.288B | 39.44 |
MacroGenics (MGNX) | United States | $0.257B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.233B | 14.69 |
Omeros (OMER) | United States | $0.223B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.213B | 0.00 |
High Tide (HITI) | Canada | $0.171B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
FitLife Brands (FTLF) | United States | $0.155B | 21.96 |
Capricor Therapeutics (CAPR) | United States | $0.151B | 0.00 |
Veru (VERU) | United States | $0.140B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.133B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.105B | 0.00 |
Fonar (FONR) | United States | $0.101B | 10.19 |
Brainsway (BWAY) | Israel | $0.099B | 0.00 |
InterCure (INCR) | Israel | $0.093B | 15.77 |
Cellectar Biosciences (CLRB) | United States | $0.085B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.43 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
Safety Shot (SHOT) | United States | $0.060B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
Modular Medical (MODD) | United States | $0.050B | 0.00 |
Bright Green (BGXX) | United States | $0.050B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.048B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 15.52 |
ImmuCell (ICCC) | United States | $0.032B | 0.00 |
Exagen (XGN) | United States | $0.031B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
Agape ATP (ATPC) | $0.015B | 0.00 | |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |